FindTrial
Sign In

1-month DAPT

DRUG5 trials

Sponsors

Kyoto University, Graduate School of Medicine, iVascular S.L.U., Shanghai Zhongshan Hospital, Ulsan University Hospital

Conditions

Acute Coronary SyndromeChronic Coronary SyndromeCoronary Artery DiseaseCoronary Artery Disease (CAD)

Phase 3

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
Active, not recruitingNCT05952206
iVascular S.L.U.Coronary Artery Disease
Start: 2023-10-13End: 2030-01-13Updated: 2026-05-15

Phase 4

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
CompletedNCT02619760
Kyoto University, Graduate School of MedicineCoronary Artery Disease
Start: 2015-12-31End: 2023-12-31Updated: 2024-06-14
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
Active, not recruitingNCT04609111
Kyoto University, Graduate School of MedicineAcute Coronary Syndrome
Start: 2021-01-29End: 2025-12-31Updated: 2024-06-14
OPtimization of Antiplatelet Therapy After the intervenTION of de Novo Coronary Artery Lesions With Drug-Coated Balloons
Not yet recruitingNCT07815106
Shanghai Zhongshan HospitalChronic Coronary Syndrome
Start: 2026-10-01End: 2029-09-30Target: 2122Updated: 2026-09-11

Unknown Phase

1-Month Versus 6-Month Dual Antiplatelet Therapy After Successful Drug-Coated Balloon-Only Percutaneous Coronary Intervention
Not yet recruitingNCT07879430
Ulsan University HospitalCoronary Artery Disease (CAD)
Start: 2026-10-19End: 2029-10-31Target: 1258Updated: 2026-10-16

Related Papers

Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.
2026-03-18
Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy.
2025-11-13
Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation
Circulation Cardiovascular Interventions2025-09-242 citations
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation.
2025-06-041 citations
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial
Circulation Cardiovascular Interventions2025-05-143 citations
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
European Heart Journal - Cardiovascular Pharmacotherapy2025-01-25
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial
European Heart Journal2024-08-3127 citations
Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial.
2024-07-062 citations
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
2024-05-015 citations
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
Circulation2023-11-23120 citations
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
JACC Asia2023-01-1015 citations
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.
2022-12-1411 citations
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
Circulation Cardiovascular Interventions2022-08-0128 citations
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
JAMA Cardiology2022-03-02274 citations
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 Trial
Circulation Cardiovascular Interventions2021-05-0130 citations
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2.
2020-11-128 citations
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.
2020-02-2141 citations
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
JAMA2019-06-25800 citations